Can e-cigarette use cause asthma?

Boston Phar­ma­ceu­ti­cals suc­ceed­ed on two close­ly watched ef­fi­ca­cy end­points for its Phase 2 MASH study, putting the com­pa­ny in con­tention with oth­er biotechs seek­ing to

Mer­dad Parsey, Gilead’s chief med­ical of­fi­cer, will leave the com­pa­ny at a time when its pipeline has stalled and it’s faced sev­er­al ma­jor stum­bles in

There are too many Covid vac­cines in de­vel­op­ment, and many oth­er in­fec­tious dis­eases where lit­tle work is get­ting done by biotech and phar­ma com­pa­nies. That’s